Rangsima Reantragoon
Overview
Explore the profile of Rangsima Reantragoon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
2081
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khanaruksombat S, Buranapraditkul S, Thantiworasit P, Suthumchai N, Rerknimitr P, Reantragoon R, et al.
Exp Dermatol
. 2024 Nov;
33(11):e70007.
PMID: 39487714
Drug reactions with eosinophilia and systemic symptoms (DRESS) and Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) are severe cutaneous adverse hypersensitivity reactions with distinct clinical manifestations. Regulatory T (Treg) cells may behave...
2.
Sengprasert P, Waitayangkoon P, Kamenkit O, Sawatpanich A, Chaichana T, Wongphoom J, et al.
Sci Rep
. 2024 Aug;
14(1):18043.
PMID: 39103466
In osteoarthritis (OA), extracellular matrix (ECM) digestion by cartilage-degrading enzymes drives cartilage destruction and generates ECM fragments, such as proteoglycan aggrecan (PG) peptides. PG peptides have been shown to induce...
3.
Hengtrakool P, Leearamwat N, Sengprasert P, Wongphoom J, Chaichana T, Taweevisit M, et al.
Front Immunol
. 2024 Feb;
15:1326953.
PMID: 38361943
Objectives: In knee osteoarthritis (OA), macrophages are the most predominant immune cells that infiltrate synovial tissues and infrapatellar fat pads (IPFPs). Both M1 and M2 macrophages have been described, but...
4.
Sengprasert P, Kamenkit O, Tanavalee A, Reantragoon R
J Rheumatol
. 2023 Nov;
PMID: 37914220
Osteoarthritis (OA) is a disease in which the pathogenesis affects the joint and its surrounding tissues. Cartilage degeneration is the main hallmark of OA and chondrocytes within the cartilage regulate...
5.
Mifsud N, Illing P, Ho R, Tuomisto J, Fettke H, Mullan K, et al.
Allergy
. 2023 Jul;
78(11):2980-2993.
PMID: 37452515
Allopurinol (ALP) is a successful drug used in the treatment of gout. However, this drug has been implicated in hypersensitivity reactions that can cause severe to life-threatening reactions such as...
6.
Suthumchai N, Buranapraditkun S, Thantiworasit P, Rerknimitr P, Wongpiyabovorn J, Khanaraksombat S, et al.
J Eur Acad Dermatol Venereol
. 2023 Feb;
37(7):1375-1384.
PMID: 36840393
Background: Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug reactions with eosinophilia and systemic symptoms (DRESS) are both severe cutaneous adverse reactions. Keratinocyte death is much more prominent in SJS/TEN compared...
7.
Ruenjaiman V, Sodsai P, Kueanjinda P, Bunrasmee W, Klinchanhom S, Reantragoon R, et al.
J Microbiol Immunol Infect
. 2022 Oct;
55(6 Pt 1):993-1004.
PMID: 36220753
Backgrounds: SARS-CoV-2 infection results in a broad spectrum of clinical outcomes, ranging from asymptomatic to severe symptoms and death. Most COVID-19 pathogenesis is associated with hyperinflammatory conditions driven primarily by...
8.
Boonpattanaporn N, Kongkaew T, Sengprasert P, Souter M, Lakananurak N, Rerknimitr R, et al.
J Leukoc Biol
. 2022 Jun;
112(4):717-732.
PMID: 35704477
Mucosal-associated invariant T (MAIT) cells are innate-like, unconventional T cells that are present in peripheral blood and mucosal surfaces. A clear understanding of how MAIT cells in the mucosae function...
9.
Seneviratna R, Redmond S, McWilliam H, Reantragoon R, Villadangos J, McCluskey J, et al.
Immunol Cell Biol
. 2022 Feb;
100(3):218.
PMID: 35168300
No abstract available.
10.
Kongkaew T, Thaiwong R, Tudsamran S, Sae-Jung T, Sengprasert P, Vasuratna A, et al.
J Immunol Methods
. 2022 Feb;
503:113229.
PMID: 35101548
Tumor infiltrating lymphocytes (TILs) are cells that are present inside the tumor environment, of which include T cells, B cells and natural killer (NK) cells. At present, TILs are used...